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Emerging infectiousdiseases (EIDs) have contributed significantly to the current
biodiversity crisis, leading towidespread epidemics andpopulation loss.Owing
to genetic variation in pathogen virulence, a complete understanding of species
decline requires the accurate identification and characterization of EIDs. We
explore this issue in theWestern honeybee, where increasingmortality of popu-
lations in the Northern Hemisphere has caused major concern. Specifically, we
investigate the importance of genetic identity of the main suspect in mortality,
deformedwing virus (DWV), in driving honeybee loss. Using laboratory exper-
iments and a systematic field survey, we demonstrate that an emerging DWV
genotype (DWV-B) is more virulent than the established DWV genotype
(DWV-A) and is widespread in the landscape. Furthermore, we show in a
simple model that colonies infected with DWV-B collapse sooner than colonies
infected with DWV-A. We also identify potential for rapid DWV evolution by
revealing extensive genome-wide recombination in vivo. The emergence of
DWV-B in naive honeybee populations, including via recombination with
DWV-A, could be of significant ecological and economic importance. Our find-
ings emphasize that knowledge of pathogen genetic identity and diversity is
critical to understanding drivers of species decline.1. Introduction
Emerging infectious diseases (EIDs) are a worldwide threat to biodiversity, food
security and human health [1–3]. Prominent examples include lethal
chytridiomycosis, a major cause of on-going amphibian species declines globally
[4], and white-nose syndrome, an EID that has caused large-scale population
losses of bats [5]. Recent studies have indicated a possible role for genetic diversity
[6,7] and the influence of the global spread of pathogens [8] in these declines.
Bees, which provide the essential ecosystem service of pollination, are
required for the production of many food crops [9]. Yet they are under pressure
globally [10–18], with EIDs being implicated as a principle cause of decline
[10–13,16,19,20]. Losses of the most important commercial pollinator, the Wes-
tern honeybee (Apis mellifera), are an ongoing major concern in the Northern
Hemisphere [10–12,19]. Alongside colony collapse disorder, which has so far
only been observed inside the USA [12], overwinter colony loss is the principle
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Northern Hemisphere [21,22].
Deformed wing virus (DWV) and its vector, the parasitic
mite Varroa destructor [23], have been strongly implicated as
causal factors of honeybee loss. The arrival of the V. destructor
mite precipitated a novel transmission route for viruses to
enter bee haemolymph directly, resulting in the ability for
DWV to generate infections very rapidly. Varroa destructor
is linked with massively increased DWV titres and low
viral genotypic diversity [24] and it is likely that emergence
of RNA viruses has led to substantially decreased mite
infestation thresholds for honeybee colony loss [25,26].
It is widely appreciated that DWV is a good indicator of
colony decline owing to its positive temporal correlation
with honeybee colony losses [27–35]. However, as with cor-
relational relationships between other insect diseases and
RNA virus infection [36], explicit tests of the relationship
between defined genetic variants of DWV and honeybee
host mortality have been lacking.
To understand if genetic variation in circulating honeybee
pathogens could be a major determining factor of honey-
bee loss, we performed laboratory assays on pathogen
virulence using two well-defined genotypic variants of
DWV (DWV-A and DWV-B). We compared the mortality
of honeybees infected with each virus genotype separately
or when infected with an equal mix of both genotypes. We
then asked if recombination could act a potential source of
rapid evolutionary change by testing for it in vivo during
experimental co-infection using both genotypes. Finally, we
conducted a systematic field survey of Great Britain (GB) to
gain an understanding of the wider prevalence of both
virus genotypes in the field.2. Methods
(a) Cage experiment
Honeybee brood was collected from three colonies kept on the
V. destructor-free island of Colonsay (Scotland). While honeybees
from the island of Colonsay have never been exposed to
V. destructor, both DWV-A and DWV-B (also known as Varroa
destructor virus, VDV-1) can be detected there, though rarely
(V. Doublet, R. J. Paxton, M. E. Natsopoulou, D. P. McMahon
2010, unpublished data), indicating that the sourced population
is not entirely naive to either virus genotype. To simulate the
role of viral infection through transmission by V. destructor,
newly emerged bees were injected through the intersegmental
membrane between the third and fourth abdominal segment
with 1 ml of 0.5 M potassium phosphate buffer pH 8.0 (PBS) con-
taining 107 genome equivalents of DWV-A (A); DWV-B (B);
DWV-A þ DWV-B (5  106 genome equivalents of each) (M);
or an equivalent virus-free extract (C).
Inoculum was prepared as follows. First, batches of 10 white-
eyed pupae were injected with field-derived individual bee
extracts containing 104 DWV-A or -B genome equivalents. Prior
to propagation, field extracts were crushed in cold 0.5 M PBS
(pH 8.0), using a plastic pestle, re-filtered through cotton wool,
and centrifuged at 48C for 15 min at 15 000 g, before extracting
the supernatant, quantifying viral titres (see section Pathogen
detection) and diluting in PBS to the required concentration.
After 6 days, injected pupae were crushed in mesh-filtered Bio-
bags (Bioreba) in cold 0.5 M PBS (pH 8.0) and purified as
above. Viral titres in inocula were quantified and stored at
2808C until used in experiments. Prior to injection, the A inocu-
lum was diluted 1.7 relative to B to equalize doses (electronicsupplementary material, table S1a). Control inoculum was
prepared from a parallel batch of uninfected white-eye pupae.
The contents of B and A inocula were analysed in detail
by ultra-deep sequencing on an Illumina platform (GATC
Biotech) as two separate libraries (‘M1’ and ‘M2’, respectively;
electronic supplementary material, table S2). Sequenced reads
were mapped to the A. mellifera reference genome (v. 4.5) and tran-
scriptome (OGS v. 3.2) using BOWTIE v. 2 [37]. Unmapped reads
were assembled into contigs of length greater than or equal to
200 nt by the VICUNA de novo assembler [38]. We then used
BOWTIE v. 2 to map reads to the contigs and NCBI Blast (mega-
blast) [39] to search for similarities between the contigs and the
NCBI nucleotide collection (nt, version from 20 November 2014,
downloaded from ftp://ftp.ncbi.nlm.nih.gov/blast/db). Detailed
description of inoculum characterization by ultra-deep sequencing
is given in the electronic supplementary material.
Experimentally injected adult bees were monitored for 24 h
to confirm that mortality associated with manipulation did not
exceed 10%. Bees from each source colony were mixed evenly
(six per colony), held in autoclaved metal cages (18 individuals
per cage) in an incubator at þ308C and dead bees were counted
and removed every 24 h. Bees were fed ad libitum with 50%
(w/v) sucrose solution. Each treatment consisted of four inde-
pendent replicate cages. An independent subset of bees was
freeze-killed in liquid N2 at 9 days (n ¼ 5) and 13 days (n ¼ 3)
post-infection (p.i.) for post hoc virus analysis. We quantified
DWV-A and -B across treatments (electronic supplementary
material, table S1b,c), and confirmed that bees were negative for
potential background viruses by qRT-PCR: chronic bee paralysis
virus (CBPV); acute bee paralysis virus (ABPV); Israeli acute paraly-
sis virus (IAPV); black queen cell virus (BQCV); slow bee paralysis
virus (SBPV) and sac brood virus (SBV).(b) Pathogen detection
Total RNA of individual workers from cage experiments was
obtained using the RNeasy mini kit (Qiagen) in a QIAcube
robot (Qiagen) following manufacturer’s instructions. Whole
bees were macerated in 500 ml RLT buffer using a plastic
pestle, 100 ml of which was used for RNA isolation. For the
experimental inocula, 80 ml of purified supernatant was used
for viral RNA isolation. In the GB field survey, methods are as
previously described [20].
Total cDNA of cage experiment samples, in addition to
experimental inocula, was synthetized using M-MLV Revertase
(Promega) following manufacturer’s instructions, using 800 ng
of sample RNA. cDNA samples were diluted 1 : 10 prior to use
in qRT-PCR. For absolute quantification, qRT-PCR was per-
formed with a Bio-Rad C1000, using SYBRgreen Sensimix
(Bioline) in the following programme: 5 min at 958C, followed
by 40 cycles of 10 s at 958C, 30 s at 578C, and 30 s at 728C
(read). RP49 was amplified for all samples as an internal refer-
ence marker. Following PCR, DNA was denatured for 1 min at
958C and cooled to 558C for 1 min. A melting profile was gener-
ated from 558C to 958C (0.58C per second increments).
We applied an upper cycle threshold (Ct) of 35 for positive
DWV-A and -B detection to minimize risk of false positives
[40]. Absolute quantification of DWV-A and -B was calculated
using duplicate DNA standard curves of purified flanking PCR
products (DWV-A and -B) with efficiencies between 93% and
100% and correlation coefficients (R2)  0.988.
We employed recently developed primers [41] for amplifica-
tion of the RNA-dependent RNA polymerase gene (RdRp), and
confirmed DWV-A and -B primer specificity by conducting
RT-PCRs from a mixed sample containing both DWV-A and -B
virus, and sequencing 29 and 38 cloned PCR products for each
primer pair, respectively. All sequences could be unambiguously
matched to the expected virus target (electronic supplementary
Table 1. Final Cox proportional hazard model of cage mortality following experimental inoculation. (C, control; A, DWV-A; B, DWV-B; M, mixed DWV-A and -B.
s.e., standard error; s.d., standard deviation.)
coefﬁcients model testing
parameters b s.e. (b) Exp. (b)a x2 (LRT) d.f. p-value
ﬁxed variable
treatment 50.706 3 ,0.00001*
C 0 — 1
A 4.643 0.619 103.865
B 6.480 0.643 651.826
M 6.093 0.638 442.705
random variable s.d. variance
cage 0.403 0.162
aEquivalent to the hazard ratio, the instantaneous risk of death for bees in each treatment compared with the baseline treatment level (in this case C). Higher
levels of b indicate higher risk of death.
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viously [41]. A list of all primers used in PCR is given in
electronic supplementary material, table S4.(c) Determination of recombinants
We first determined the precise sequences of the DWV-A and
DWV-B genomes in our assay by aligning the Illumina
sequenced reads from the inoculum datasets onto their respect-
ive reference sequences (accession numbers NC_004830.2 and
NC_006494.1, respectively) using BOWTIE v. 2 [37] (electronic sup-
plementary material, figure S1a) and generating consensus
sequences from the aligned sequencing reads. The DWV-A con-
sensus differed by 200 bp (198 mismatches, two insertions; 98.0%
sequence similarity) and the DWV-B consensus sequence by
76 bp (75 mismatches, one insertion, 99.3% sequence similarity)
from their respective reference sequences. The sequence simi-
larity of our genome consensus for DWV-A to our genome
consensus for DWV-B was 84.2% (1580 mismatches, 28 insertions
and deletions; electronic supplementary material, figure S2a) and
each genotype varied by less than 0.1% across its genome (elec-
tronic supplementary material, figure S1a), indicating that the
two viral inocula did not form a single, interconnected mutant
cloud or quasi-species.
Illumina sequencing data were generated from a third library
(‘M3’) of five pooled 9d p.i. M-treated honeybees (23 546 472
reads in total) and were processed as follows. First, all sequen-
cing read pairs with overlapping ends (2 602 106 reads, 11.1%)
were discarded from the analysis. The remaining reads pairs
were mapped on both consensus sequences. We assumed that
a single read (101 bp) originated from DWV-A rather than
DWV-B if it matched with at most one mismatch to DWV-A,
and with at least six further mismatches to DWV-B. Conversely,
we assumed that a single read originated from DWV-B rather
than DWV-A if it matched with at most one mismatch to
DWV-B, and with at least six further mismatches to DWV-A.
We then defined recombinant read pairs as ‘discordant’ if they
met all four of our criteria: (i) one read of a pair originated
from DWV-A and the other from DWV-B; (ii) the mapping pos-
itions of the two read ends did not overlap; (iii) the read with the
lower mapping position was mapped on the plus strand of the
virus genome while the other read with the higher mapping pos-
ition was mapped on the minus strand; and (iv) the distancebetween the 50 ends of the mapped read ends (i.e. the fragment
length) was at most 500 bp.
(d) Great Britain survey of deformed wing virus-A and -B
Honeybee foragers from 25 sites across GB (electronic sup-
plementary material, figure S3) were previously screened for
DWV-related viruses [41], wherein the RdRp region was ampli-
fied by qRT-PCR to assess the prevalence and individual loads
of viruses belonging to the DWV complex (including DWV-A
and -B). We re-examined the data by treating DWV-A and -B
results separately.
(e) Statistical analyses
All analyses were performed in R v. 3.1.3 [42]. Survivorship of
experimentally inoculated bees was analysed, using Cox pro-
portional hazard models (R packages ‘coxme’ and ‘coxph’)
[43,44]. Models contained cage-replicate and treatment as
random and fixed effects, respectively (‘coxme’; table 1), except
where survival curves were depicted graphically in that case
‘cage’ as a random term could not be incorporated into curve fit-
ting (‘Survfit’ function of a ‘coxph’ object; figure 1; electronic
supplementary material, figure S4). The R package ‘multcomp’
[46] was used for comparing significant differences between
treatment means, using Bonferroni correction to account for mul-
tiple testing. Moran’s I indices were estimated in ‘ape’ [47]. All
raw data files and code used in analyses are available in Dryad
[48]. Sequenced Illumina reads from the DWV-A and -B inocula
(libraries M2 and M1 respectively) and mixed-infection library
(M3) are available from the Sequence Read Archive (BioProject
PRJNA325785) and sequenced cloned PCR products are
available from GenBank (accession nos. KX265618–KX265684).
The impact of DWV-A and -B on colony survival was
explored using the BEEHAVE-Model (BEEHAVE-Model version
2014-03-04, www.beehave-model.net) [45]. BEEHAVE simulates
realistic honeybee colony growth and foraging dynamics and
can be used to explore how honeybee colonies may be impacted
by stressors manipulated either singly or in combination. To
simulate the effect of DWV-A and -B on colony performance,
the Mite-module within the BEEHAVE model was employed.
Two scenarios were compared: (i) default settings with Varroa/
DWV (i.e. DWV-A) infection as described in reference [48]
(10 virus-free mites and 10 virus-carrying mites introduced on
day 0); and (ii) As setting (i) but with simulated infection by
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Figure 1. Test of DWV virulence under controlled conditions. (a) Fitted Cox
proportional hazard survival curves (solid coloured lines) in days post-
infection ( p.i.) following exposure by injection of V. destructor-free, newly
emerged adults. C ¼ control (black); A ¼ DWV-A (blue); B ¼ DWV-B
(green); M ¼ mix (orange) and 95% CIs for each fitted curve (dashed
coloured lines). Star/lines show significant differences between treatments
( p , 0.05) based on post hoc pairwise comparisons of the final model in
table 1. Median survival of control bees was 29 days, for DWV-A injected
bees it was 18 days, and for DWV-B injected bees it was 13.5 days.
(b) DWV-A and -B titres in A, B and M treatments from bees extracted at
9 and 13 days p.i. (c) Population dynamics over time of colonies infected
with DWV-A or -B. Models were run in BEEHAVE [45] with Mite-model par-
ameters adjusted to reflect the relative individual mortality of adults and
pupae infected with either DWV-A or -B. Individual daily mortality rates
were derived from laboratory experiment survival data ( panel (a); described
in Methods). Colony collapse events are indicated by a vertical red arrow.
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of adult bees compared with DWV-A. Daily mortality rates
of bees were derived from our experimental data at the day
of 50% survivorship (1 – [median survival
p
0.5] ¼ daily mortalityrate). Model mortality rates were calculated by calibrating the
daily cage experiment mortality rate to the default values in
the BEEHAVE model (0.004 and 0.012 for background and
DWV-A mortality, respectively). The relative mortality rate of
DWV-B used in scenario (ii) was then extrapolated from these
values (i.e. 0.016). We applied these values to two variables
controlling adult and pupal mortality, respectively, but a conser-
vative model was also conducted where only the adult mortality
rate was altered. Both scenarios were run until the death of the
colony (i.e. a colony was presumed dead when there were less
than 4000 bees at the end of a calendar year). A detailed descrip-
tion of the adjusted model parameters is given in the electronic
supplementary material, table S5.3. Results
(a) Cage experiment
Characterization of experimental inocula by ultra-deep
sequencing revealed very low variability within (ca 0.04%)
but high variability between (ca 16%) DWV-A and -B inocula.
We found no evidence of co-occurring honeybee-associated
organisms, inclusive of another recently characterized
DWV genotype (DWV-C; electronic supplementary material,
table S2 and figures S1, S2)
We experimentally exposed naive adult workers to inocula
containing field-derived DWV-A and -B in the absence of its
biological vector, V. destructor, to investigate the importance
of DWV genetic variation for honeybee host virulence
(figure 1a). Median survival in days for treatments C, A, B
and M was as follows (95% CIs): 29 (28–30), 18 (18–19), 13.5
(13–14) and 14 (13–14), corresponding to a daily mortality
rate of 0.024, 0.038, 0.050 and 0.048, respectively. Survival
was significantly reduced by all virus treatments compared
with the control (Tukey post hoc comparison of model means
(Bonferroni corrected): B versus C: z ¼ 210.08, p, 0.0001;
A versus C: 27.503, p , 0.0001; M versus C: z ¼ 29.552,
p , 0.0001). B was significantly more virulent than A
(z ¼ 25.317, p, 0.0001). Furthermore, M was significantly
more virulent than A (z ¼ 24.276, p, 0.0005), but not
B (z ¼ 1.167, p ¼ 1.00). The final model output is given
in table 1.
A post hoc qRT-PCR screen of a subsample of bees
collected 9d and 13d p.i. showed that virus-injected bees
each contained more than 1011 DWV-A or -B genome equiva-
lents in the A and B-injected treatments, respectively, and
that C-injected bees were free of both viruses (electronic sup-
plementary material, table S1). Additionally, DWV-B titres in
B-injected bees were higher than DWV-A titres in A-injected
bees at 9d p.i. but not 13d p.i. (Wilcoxon signed-rank test
W ¼ 0, p, 0.001 and W ¼ 2, p ¼ 0.4, respectively), possibly
because of mortality of heavily infected bees from treatment
B between 9d and 13d p.i. Likewise, DWV-B titres were
higher than DWV-A titres in M-injected bees at 9d p.i. but
not 13d p.i. (Wilcoxon signed-rank test W ¼ 0, p, 0.001
and W ¼ 2, p ¼ 0.4, respectively; figure 1b). We also found
that some B-injected bees sampled at 9d p.i. contained very
low levels of DWV-A but that bees sampled at 13d p.i.
were free of the co-occurring virus (electronic supplementary
material, table S1).
To confirm that differential virulence was owing to
inherent differences between DWV-A and -B and not owing
to the different composition of the starting inocula, we reana-
lysed mortality across the treatments starting from day 13,
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These yielded the same results as above between all treatment
comparisons (electronic supplementary material, figure S4
and table S6): B versus C: z ¼ 29.147, p, 0.0001; A versus
C: z ¼ 27.067, p, 0.0001; M versus C: z ¼ 28.685, p,
0.0001; M versus A: z ¼ 23.008, p ¼ 0.016; M versus B: z ¼
0.900, p ¼ 1.0; A versus B: z ¼ 23.832, p ¼ 0.0008.
To understand whether the differences in DWV-A and -B
virulence detected in the laboratory were also meaningful at
the colony-level, we modelled whole colony population
dynamics using individual bee mortality rates extrapolated
from our laboratory survival data (see Methods). We found
that, when infected with DWV-A, colonies survived four
complete annual cycles, whereas colonies that were infected
with DWV-B survived only three complete annual cycles
(figure 1c). Regardless of whether model scenario (i) or (ii)
was used (electronic supplementary material, figure S5),
colony collapse occurred during the fourth and fifth winter
for DWV-B and -A infected colonies, respectively.
(b) Recombination
In total, we detected 19 984 discordant read pairs, which were
used to infer recombinants (electronic supplementary
material, figure S2b); both read pairs of 13 513 751 sequences
matched uniquely to either DWV-A or -B. This re-confirmed
that experimental honeybees contained high titres of DWV-A
and -B to the exclusion of other common honeybee viruses or
unintended DWV genotypes (DWV-C). Significantly, our ana-
lyses of discordant read-pairs revealed extensive evidence of
recombination across the genome (electronic supplementary
material, figure S2).
(c) Field prevalence: country-wide survey of deformed
wing virus -A and deformed wing virus-B
We examined the data from a recent field survey of honeybee
foragers at 25 sites across GB [41] to understand the preva-
lence and therefore the wider potential impact of DWV-B
across honeybee populations. We found that DWV-B
was more prevalent than DWV-A, but this difference
was marginally non-significant in a test of proportions
(x21 ¼ 2:57; p ¼ 0.055; figure 2a). The spatial distribution of
viruses also differed (figure 2). DWV-B was largely restrictedto southern England, and was significantly clustered (Moran’s
I ¼ 0.12, p ¼ 0.005), whereas DWV-Awasmore uniformly dis-
tributed across GB (Moran’s I ¼ 20.087, p ¼ 0.432; figure 2b).
Finally, the number of co-infected individuals was higher than
expected by chance (11.45% observed versus 4.41% expected,
x2 ¼ 37.92, p, 0.0001), indicating non-independence of
DWV-A and -B infections among honeybee foragers.4. Discussion
Our findings reveal that: (i) a recently described genotypic
variant of DWV [49], described here as DWV-B following [50],
is more virulent than the established DWV-A genotype in a
controlled laboratory assay; (ii) the two genotypes readily
recombine in vivo; and (iii) DWV-B is geographically wide-
spread. Our findings demonstrate that DWV is composed of at
least twodivergent genotypes that differ significantly in biology,
and that DWV-B, either singly or as a recombinant, may
represent a particular threat to naive honeybee populations.
The ongoing biodiversity crisis is exacerbated by interactions
among a multitude of stressors, including pathogens, pesticides,
habitat degradation, overexploitation, climate change and exotics
introduced through commercial trade [16,51]. In honeybees,
the arrival of a novel disease vector in the form of V. destructor
created an opportunity for dramatically increased pathogen
transmission, which may have triggered a shift towards
increased virulence in viruses such as DWV that were already
present in honeybee populations, but had previously persisted
as low-level asymptomatic infections. However, whether
emerging pathogen diversity itself could be a major driving
force of honeybee population decline, as may be the case in
amphibians [6,7,52], cannot yet be determined.
The status of DWV-B outside of Europe is not well under-
stood. A recent study implicated DWV-B alongside DWV-A
and V. destructor infestation as a causal factor in colony decline
in the southern USA [34], although DWV genotypes were
identified indirectly in this study (by probe hybridization and
not by sequencing). Another study did not detect significant
levels of DWV-B in North America [53]. These findings high-
light the considerable lack of understanding concerning the
global distribution of genotypic variants of DWV. A recent
analysis found the global pandemic of DWV to be mediated
by European honeybee populations [54], and that North
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World. This demonstrates that Europe may be an important
source of and/or route for the global spread of emerging and
re-emerging DWV strains. Unfortunately, detailed knowledge
of the global phylogeography of genotypes such as DWV-B is
currently lacking. For example, it is possible that the spread
of DWV-B to the USA occurred recently and/or is currently
ongoing. However, this remains speculative until a systematic
survey of viral population variation is conducted. Such infor-
mation is needed to improve knowledge of the origins, levels
of endemism and current prevalence of different DWV
genotypes.
In addition to field studies, laboratory experiments are
required to assess comparative virulence across a broader
range of representative DWV and host genotypes. For
example, a novel DWV-C genotype has also recently been
reported in the UK and Hawaii [50] but detailed knowledge
concerning its origins, global prevalence and impact both in
the field and under controlled laboratory conditions are
needed. Because our study reports virulence from a single
population, further research is also required to test the
extent to which elevated DWV-B virulence can be extrapo-
lated to other host honeybee genotypes. The combination
of such data can then be used to assess the potential risk
of emergence of specific viral genotypes to honeybee
populations across temperate zones.
While DWV-A and -B are justifiably considered to belong
to the same complex due to nucleotide sequence and proteo-
lytic cleavage site similarity [55], our data demonstrate that
considering them as synonymous in terms of their underlying
biology could be misleading. DWV-A and -B have been
described as belonging to a single quasi-species [55], but
given the genetic distance separating the two genotypes
(approx. 16% at the nucleotide level), in addition to marked
geographical and phenotypic differences that we show here
to result in a significant difference in host fitness, we argue
that it is unhelpful to consider DWV-A and -B as epidemiolo-
gically or evolutionarily equivalent. Indeed, these genotypes
are the result of evolutionary processes that have taken
place over medium-term timescales [50,54]. Use of the term
‘genotype’ to describe DWV-A and -B is consistent with viro-
logical nomenclature, where a ‘genotype of a virus can be
viewed as a set of related genomes that have found a
high fitness domain and acquired epidemiological relevance
associated with replicative or non-replicative traits’ [56].
In a comparative test of mortality in naive bees, our
data show that DWV-B is more virulent than DWV-A and
that this may be attributable to a superior rate of replica-
tion in honeybees. The difference in virulence we detected
translates into a reduction in median lifespan of 38% for
DWV-A injected bees versus 53.5% for DWV-B, against
control-injected bees. Such a decrease in the median lifespan
of the workforce could have a significant impact on the
colony as a whole. We tested this by modelling colony popu-
lations in the presence of either DWV-A or -B, finding that
colonies collapse 1 year earlier when infected with DWV-B
when compared with DWV-A. This is in agreement
with findings from RNA viruses and other pathogens in
other systems, where significant differences in virulence
among closely related genotypes are commonplace for dis-
eases of both humans [57–59] and wildlife [60,61], with
major repercussions for transmission dynamics and epide-
mic potential. While this possibility has been widelydiscussed for bee viruses [32,62–66], it has not been explicitly
tested until now.
Recombinationmay act as a powerful generator of chimeric
DWV genotypes [67–69], which may lead to significant geno-
type mixing. For instance, our field data demonstrate that
forager honeybees co-infected with both DWV-A and -B
occur more commonly than expected by chance, though the
extent to which this reflects recombination is unclear. We also
show in an experimental setting that DWV-A and -B readily
recombine at sites across the genome when the two genotypes
are present at high levels during co-infection. Together, these
point to potential for extensive generation of recombinant gen-
otypes via genome-wide recombinationmechanisms, although
the extent of recombination actually taking place in the field
still remains to be determined. Such processes could in
theory have important knock-on effects for long-termvirulence
evolution and host adaptation [70]. Indeed, naturally occurring
recombinants composed of DWV-A and -B have recently been
reported [67,68], and the discovery of chimeric DWV-A/B
viruses has been linked to higher virulence in honeybee
pupae [69]. For example, a recent report of superinfection
exclusion of DWV-A by DWV-B [71] could also be owing to
a novel A/B recombinant.
It has been hypothesized that DWV-B derived capsid pep-
tides could facilitate horizontal transmission via V. destructor
and that DWV-A derived non-structural proteins (e.g. internal
ribosome entry site) might permit higher (host-specific) repli-
cation in honeybee cells [67]. However, specific associations
between DWV-B and V. destructor, or between DWV-A and
A. mellifera have not been empirically tested. Additionally,
aside from the V. destructor sample fromwhich it was isolated,
we see no a priori reason to suspect that the DWV-B genotype
might be more or less adapted to either V. destructor or
A. mellifera, when compared with DWV-A. Rather, our find-
ings indicate that DWV-B replication in A. mellifera may in
fact be superior to that of DWV-A. Regardless of any uncer-
tainty over the putative adaptive origins of DWV-A and -B,
the potential for novel strains with significantly altered
virulence dynamics to emerge via recombination should
be acknowledged, and incorporated into future honeybee
pathogen detection and mitigation strategies.5. Conclusion
DWV-B is widespread in the landscape and it is more viru-
lent than the original DWV-A genotype in the laboratory.
Explaining how V. destructor influences epidemiology, both
as a biological vector and putative second host, is central to
improving our understanding of the continuing impact of
both DWV-A and -B [72]. In this regard, we argue that the
explicit inclusion of honeybee—V. destructor— virus inter-
actions into related research questions such as intracolony
dynamics [23,73] and immunity (particularly in relation to
pesticide use) [74] is important. The continuing decline of
wild pollinators such as bumblebees [13–15], alongside
recent evidence of widespread and on-going spillover of
V. destructor vectored RNA viruses between managed and
wild bees [20,41], also demonstrates the wider potential for
disease emergence in other bee pollinators. Our findings
emphasize the importance of understanding the wider
extent of pathogen genetic diversity when investigating
causes of species decline, and highlight the need for a
rspb.royalsocietypublishing.org
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